|
31623.01.01
|
ALECENSA CAPS 150MG/CAP BTx224 (4 PACKS x56) σε alu/alu perforated blister
|
|
4.600,64 € |
5.116,86 € |
5.532,35 € |
Roche Registration Ltd
|
|
26769.01.01
|
AVASTIN C/S.SOL.IN 100 MG/4 ML BT x 1 VIAL x 4 ML
|
|
226,52 € |
251,93 € |
299,09 € |
Roche Registration Ltd
|
|
26769.02.01
|
AVASTIN C/S.SOL.IN 400 MG/16 ML BT x 1 VIAL x 16 ML
|
|
842,56 € |
937,10 € |
1.047,96 € |
Roche Registration Ltd
|
|
22731.02.02
|
BONDRONAT C/S.SOL.IN 2MG/2ML BTx1VIALx2ML
|
|
66,72 € |
76,69 € |
108,14 € |
Roche Registration Ltd
|
|
22731.04.01
|
BONDRONAT C/S.SOL.IN 6MG/6ML VIAL BT x 1 VIAL x 6 ML
|
|
63,61 € |
73,11 € |
92,99 € |
Roche Registration Ltd
|
|
22731.05.01
|
BONDRONAT F.C.TAB 50MG/TAB BTx28 (4 BLIST x7)
|
|
60,96 € |
70,07 € |
89,12 € |
Roche Registration Ltd
|
|
26978.02.01
|
BONVIVA F.C.TAB 150 MG/TAB BTx1(BLIST PVC/PVDC)
|
|
7,60 € |
8,74 € |
12,04 € |
Roche Registration Ltd
|
|
26978.02.02
|
BONVIVA F.C.TAB 150 MG/TAB BTx3(BLIST PVC/PVDC)
|
|
36,02 € |
41,40 € |
58,38 € |
Roche Registration Ltd
|
|
26978.03.01
|
BONVIVA INJ.SOL 3MG/3ML BTx1 PF. SYR x 3ML
|
|
23,01 € |
26,45 € |
36,45 € |
Roche Registration Ltd
|
|
22554.04.01
|
CELLCEPT C/S.SOL.IN 500MG/VIAL BTX4VIALS
|
|
28,73 € |
33,03 € |
45,52 € |
Roche Registration Ltd
|
|
22554.01.01
|
CELLCEPT CAPS 250MG/CAP BTX100(BLIST10X10)
|
|
29,63 € |
34,06 € |
46,94 € |
Roche Registration Ltd
|
|
22554.03.01
|
CELLCEPT PD.ORA.SUS 1G/5ML FLX110G
|
|
51,36 € |
59,04 € |
75,10 € |
Roche Registration Ltd
|
|
22554.02.01
|
CELLCEPT TAB 500MG/TAB BTX50(BLIST5X10)
|
|
28,41 € |
32,66 € |
45,01 € |
Roche Registration Ltd
|
|
31293.01.01
|
COTELLIC F.C.TAB 20MG/TAB BTx63 (BLIST 3x21 δισκία) σε BLISTERS PVC/PVDC
|
|
4.470,46 € |
4.972,08 € |
5.375,81 € |
Roche Registration Ltd
|
|
30570.01.01
|
ERIVEDGE CAPS 150MG/CAP BTx28 (HDPE BOTTLE) (HDPE BOTTLE)
|
|
3.781,83 € |
4.206,18 € |
4.547,72 € |
Roche Registration Ltd
|
|
30333.01.02
|
ESBRIET CAPS 267MG/CAP BTx252 (4x63) σε PVC/PE/PCTFE/alu blister
|
|
1.745,17 € |
1.941,00 € |
2.124,32 € |
Roche Registration Ltd
|
|
30333.01.01
|
ESBRIET CAPS 267MG/CAP BTx63 (1x21) και (1x42) σε PVC/PE/PCTFE/alu blister
|
|
434,66 € |
483,43 € |
558,56 € |
Roche Registration Ltd
|
|
30333.02.10
|
ESBRIET F.C.TAB 267MG/TAB 252 (84x3) δισκία σε BLISTER (PVC/Aclar(PCRFE)) - πολυσυσκευασία
|
|
1.745,17 € |
1.941,00 € |
2.124,32 € |
Roche Registration Ltd
|
|
30333.02.07
|
ESBRIET F.C.TAB 267MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCRFE))
|
|
438,14 € |
487,31 € |
563,04 € |
Roche Registration Ltd
|
|
30333.02.09
|
ESBRIET F.C.TAB 267MG/TAB Θεραπεία έναρξης 63 (1x21 & 2x21) δισκία σε BLISTER (PVC/Aclar(PCRFE)
|
|
438,14 € |
487,31 € |
563,04 € |
Roche Registration Ltd
|
|
30333.04.02
|
ESBRIET F.C.TAB 801MG/TAB 84 δισκία σε BLISTER (PVC/Aclar(PCTFE))
|
|
1.794,76 € |
1.996,14 € |
2.184,67 € |
Roche Registration Ltd
|
|
26032.01.01
|
FUZEON PS.INJ.SOL 90MG/ML 60VIALS PD.FOR INJ + 60VIALS SOLV+60SYR.x3ML+60SYR.x1ML+180 ΤΟΛΥΠΙΑ ΕΜΠΟΤ. ΜΕ ΟΙΝΟΠΝΕΥΜΑ
|
|
1.130,92 € |
1.257,82 € |
1.389,96 € |
Roche Registration Ltd
|
|
30879.01.01
|
GAZYVARO C/S.SOL.IN 1000MG/40ML BTx1 VIAL x40ML
|
|
2.833,46 € |
3.151,40 € |
3.407,30 € |
Roche Registration Ltd
|
|
31828.02.01
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 0,4 ML
|
|
4.231,11 € |
4.705,97 € |
5.088,09 € |
Roche Registration Ltd
|
|
31828.02.02
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 0,7ML
|
|
7.402,88 € |
8.233,72 € |
8.902,30 € |
Roche Registration Ltd
|
|
31828.02.03
|
HEMLIBRA INJ.SOL 150MG/ML BT x 1 VIAL x 1ML
|
|
10.574,67 € |
11.761,48 € |
12.716,51 € |
Roche Registration Ltd
|
|
31828.01.01
|
HEMLIBRA INJ.SOL 30MG/ML BT x 1 VIAL x1 ML
|
|
2.116,49 € |
2.354,03 € |
2.563,89 € |
Roche Registration Ltd
|
|
24573.02.01
|
HERCEPTIN INJ.SOL 600MG/5ML BTx1VIALx5ML
|
|
1.258,82 € |
1.400,07 € |
1.547,14 € |
Roche Registration Ltd
|
|
24573.01.01
|
HERCEPTIN PD.C.SO.IN 150 MG/VIAL BTx1VIAL(GLASS)
|
|
430,21 € |
478,48 € |
552,83 € |
Roche Registration Ltd
|
|
22874.01.01
|
INVIRASE 200MG/CAP CAPS FLx270
|
|
194,47 € |
223,53 € |
270,01 € |
Roche Registration Ltd
|
|
22874.03.01
|
INVIRASE F.C.TAB 500 mg/TAB FL x 120
|
|
172,96 € |
198,81 € |
240,24 € |
Roche Registration Ltd
|
|
30674.01.01
|
KADCYLA PD.C.SO.IN 100MG BTx1VIAL
|
|
1.390,42 € |
1.546,43 € |
1.700,69 € |
Roche Registration Ltd
|
|
30674.02.01
|
KADCYLA PD.C.SO.IN 160MG BTx1VIAL
|
|
2.222,99 € |
2.472,43 € |
2.692,85 € |
Roche Registration Ltd
|
|
23564.01.01
|
MABTHERA C/S.SOL.IN 100MG/10ML VIAL BTx2VIALSx10ML
|
|
369,92 € |
411,43 € |
475,37 € |
Roche Registration Ltd
|
|
23564.02.01
|
MABTHERA CS.INJ.SOL 500MG/50ML BTx1VIALx50ML
|
|
929,72 € |
1.034,04 € |
1.150,88 € |
Roche Registration Ltd
|
|
23564.03.01
|
MABTHERA INJ.SOL 1400MG/11.7ML BTxVIALx15ml
|
|
1.323,74 € |
1.472,28 € |
1.626,94 € |
Roche Registration Ltd
|
|
23564.04.01
|
MABTHERA INJ.SOL 1600MG/13.4ML BTxVIAL
|
|
1.772,21 € |
1.971,11 € |
2.157,28 € |
Roche Registration Ltd
|
|
27904.10.01
|
MIRCERA INJ.SO.PFS 100MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
132,21 € |
151,97 € |
183,65 € |
Roche Registration Ltd
|
|
27904.20.01
|
MIRCERA INJ.SO.PFS 120MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
160,86 € |
184,91 € |
223,45 € |
Roche Registration Ltd
|
|
27904.11.01
|
MIRCERA INJ.SO.PFS 150MCG/0,3ML PF.SYR BTx1 PF.SYR.x 0,3 ML
|
|
197,41 € |
219,56 € |
260,66 € |
Roche Registration Ltd
|
|
27904.12.01
|
MIRCERA INJ.SO.PFS 200MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
268,10 € |
298,18 € |
354,00 € |
Roche Registration Ltd
|
|
27904.13.01
|
MIRCERA INJ.SO.PFS 250MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
333,93 € |
371,40 € |
433,05 € |
Roche Registration Ltd
|
|
27904.17.01
|
MIRCERA INJ.SO.PFS 30MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
40,17 € |
46,18 € |
63,63 € |
Roche Registration Ltd
|
|
27904.21.01
|
MIRCERA INJ.SO.PFS 360MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,6 ML
|
|
484,36 € |
538,71 € |
616,72 € |
Roche Registration Ltd
|
|
27904.08.01
|
MIRCERA INJ.SO.PFS 50MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
66,01 € |
75,88 € |
96,52 € |
Roche Registration Ltd
|
|
27904.09.01
|
MIRCERA INJ.SO.PFS 75MCG/0,3ML PF.SYR. BTx1 PF.SYR.x 0,3 ML
|
|
98,93 € |
113,72 € |
139,84 € |
Roche Registration Ltd
|
|
22896.06.01
|
NEORECORMON (MULTIDOSE) PS.INJ.SOL 50000 IU/VIAL BTX1VIAL+1AMPX10ML
|
|
176,09 € |
179,61 € |
221,89 € |
Roche Registration Ltd
|
|
22896.15.01
|
NEORECORMON 10000 IU/0,6MLPREF.S INJ.SO.PFS BTx1PREF.SYR.x0,6ML
|
|
35,22 € |
40,48 € |
44,38 € |
Roche Registration Ltd
|
|
22896.15.02
|
NEORECORMON INJ.SO.PFS 10000 IU/0,6MLPREF.S BTx6 PREF.SYR.x0,6ML
|
|
287,59 € |
319,86 € |
372,96 € |
Roche Registration Ltd
|
|
22896.12.01
|
NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML
|
|
7,48 € |
7,63 € |
9,43 € |
Roche Registration Ltd
|
|
22896.12.02
|
NEORECORMON INJ.SO.PFS 2000 IU/0,3MLPREF.SY BTx6PREF.SYRx0,3ML
|
|
43,96 € |
44,84 € |
55,40 € |
Roche Registration Ltd
|
|
22896.16.01
|
NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx1PREF.SYR.x0,6ML
|
|
70,44 € |
71,85 € |
88,76 € |
Roche Registration Ltd
|
|
22896.16.02
|
NEORECORMON INJ.SO.PFS 20000 IU/0,6MLPREF.S BTx6 PREF.SYR.x0,6ML
|
|
422,61 € |
431,06 € |
491,03 € |
Roche Registration Ltd
|
|
22896.20.01
|
NEORECORMON INJ.SO.PFS 30.000IU/0,6ML PREF.SY BTx1PF.SYR.x0,6ML
|
|
109,25 € |
111,44 € |
137,67 € |
Roche Registration Ltd
|
|
22896.20.02
|
NEORECORMON INJ.SO.PFS 30.000IU/0,6ML PREF.SY BTx4PF.SYR.x0,6ML
|
|
653,37 € |
726,68 € |
820,34 € |
Roche Registration Ltd
|
|
22896.13.01
|
NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx1PREF.SYRx0,3ML
|
|
10,63 € |
10,84 € |
13,39 € |
Roche Registration Ltd
|
|
22896.13.02
|
NEORECORMON INJ.SO.PFS 3000 IU/0,3MLPREF.SY BTx6PREF.SYR.x0,3ML
|
|
65,55 € |
66,86 € |
82,60 € |
Roche Registration Ltd
|
|
22896.18.02
|
NEORECORMON INJ.SO.PFS 4000 IU/0,3MLPREF.SY BTx6PF.SYR.x0,3ML
|
|
87,23 € |
88,97 € |
109,91 € |
Roche Registration Ltd
|
|
22896.10.01
|
NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX1PREF.SYR.X0,3ML
|
|
3,47 € |
3,54 € |
4,37 € |
Roche Registration Ltd
|
|
22896.10.02
|
NEORECORMON INJ.SO.PFS 500 IU/0,3ML PREF.SY BTX6PREF.SYR.X0,3ML
|
|
16,49 € |
16,82 € |
20,78 € |
Roche Registration Ltd
|
|
22896.14.01
|
NEORECORMON INJ.SO.PFS 5000 IU/0,3MLPREF.SY BTx1PREF.SYR.x0,3ML
|
|
17,61 € |
17,96 € |
22,19 € |
Roche Registration Ltd
|
|
22896.14.02
|
NEORECORMON INJ.SO.PFS 5000 IU/0,3MLPREF.SY BTx6PREF.SYR.x0,3ML
|
|
157,83 € |
181,41 € |
219,22 € |
Roche Registration Ltd
|
|
22896.19.02
|
NEORECORMON INJ.SO.PFS 6000 IU/0,3ML PREF.SY BTx6PREF.SYR.x0,3ML
|
|
130,02 € |
132,62 € |
163,84 € |
Roche Registration Ltd
|
|
31809.01.01
|
OCREVUS C/S.SOL.IN 300MG/VIAL BTx1 VIAL x 10ML
|
|
5.046,16 € |
5.612,49 € |
6.068,22 € |
Roche Registration Ltd
|
|
25173.05.02
|
PEGASYS IN.SO.PF.P 135MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML
|
|
420,44 € |
467,62 € |
540,29 € |
Roche Registration Ltd
|
|
25173.06.02
|
PEGASYS IN.SO.PF.P 180MCG/0,5ML PF.PEN BTx4PF.PEN.x0,5ML
|
|
484,32 € |
538,66 € |
616,66 € |
Roche Registration Ltd
|
|
25173.03.01
|
PEGASYS INJ.SOL 135MCG/0,5ML BTx1PF.SYR.x0,5ML+1 INJ.N
|
|
105,11 € |
120,82 € |
148,56 € |
Roche Registration Ltd
|
|
25173.03.02
|
PEGASYS INJ.SOL 135MCG/0,5ML BTx4PF.SYR.x0,5ML+1 INJ.N INJ.N
|
|
420,44 € |
467,62 € |
540,29 € |
Roche Registration Ltd
|
|
25173.04.01
|
PEGASYS INJ.SOL 180MCG/0,5ML BTx1PF.SYR.x0,5ML+1 INJ.N INJ.N
|
|
119,41 € |
137,26 € |
168,77 € |
Roche Registration Ltd
|
|
25173.04.02
|
PEGASYS INJ.SOL 180MCG/0,5ML BTx4PF.SYR.x0,5ML+4 INJ.N INJ.N
|
|
484,32 € |
538,66 € |
616,66 € |
Roche Registration Ltd
|
|
30484.01.01
|
PERJETA C/S.SOL.IN 420MG/VIAL (30MG/ML) BTx1 VIAL x 14ML
|
|
2.303,14 € |
2.561,57 € |
2.783,15 € |
Roche Registration Ltd
|
|
28716.01.04
|
ROACTEMRA 20MG/ML BTx4 VIALS x10ML
|
|
1.114,87 € |
1.137,17 € |
1.243,04 € |
Roche Registration Ltd
|
|
28716.01.06
|
ROACTEMRA 20MG/ML BTx4 VIALS x20ML
|
|
2.196,26 € |
2.240,19 € |
2.417,75 € |
Roche Registration Ltd
|
|
28716.01.03
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x10ML
|
|
248,14 € |
275,98 € |
327,65 € |
Roche Registration Ltd
|
|
28716.01.05
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x20ML
|
|
493,25 € |
548,60 € |
628,04 € |
Roche Registration Ltd
|
|
28716.01.01
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x4ML
|
|
99,25 € |
114,09 € |
140,28 € |
Roche Registration Ltd
|
|
28716.01.02
|
ROACTEMRA C/S.SOL.IN 20MG/ML BTx4 VIALS x4ML
|
|
439,30 € |
488,59 € |
564,51 € |
Roche Registration Ltd
|
|
28716.02.01
|
ROACTEMRA INJ.SO.PFS 162mg/PF.SYR BTx4 PF.SYR
|
|
746,84 € |
830,65 € |
933,32 € |
Roche Registration Ltd
|
|
25757.03.01
|
TAMIFLU CAPS 30MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
6,83 € |
7,85 € |
10,82 € |
Roche Registration Ltd
|
|
25757.04.01
|
TAMIFLU CAPS 45MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
11,32 € |
13,01 € |
17,92 € |
Roche Registration Ltd
|
|
25757.01.01
|
TAMIFLU CAPS 75MG/CAP BTx10 σε BLISTERS (PVC/PE/PVDC/ALU) (PVC/PE/PVDC/ALU)
|
|
11,08 € |
12,73 € |
17,54 € |
Roche Registration Ltd
|
|
25757.02.01
|
TAMIFLU PD.ORA.SUS 12MG/ML BTx1Φιάλη (γυάλινη)
|
|
11,85 € |
13,62 € |
18,77 € |
Roche Registration Ltd
|
|
25757.05.01
|
TAMIFLU PD.ORA.SUS 6MG/ML BT x 1Φιάλη (γυάλινη) x 13G
|
|
7,51 € |
8,63 € |
11,89 € |
Roche Registration Ltd
|
|
27001.01.01
|
TARCEVA 25mg/TAB F.C.TAB BT x 30 (BLISTERS, PVC/Alu)
|
|
374,19 € |
430,10 € |
438,43 € |
Roche Registration Ltd
|
|
27001.02.01
|
TARCEVA F.C.TAB 100 mg/TAB BTx 30 (BLISTER, PVC/Alu) (BLISTER, PVC/Alu)
|
|
1.192,48 € |
1.326,28 € |
1.465,61 € |
Roche Registration Ltd
|
|
27001.03.01
|
TARCEVA F.C.TAB 150mg/TAB BT x 30 (BLISTERS, PVC/Alu) (BLISTERS, PVC/Alu)
|
|
1.484,82 € |
1.651,43 € |
1.816,16 € |
Roche Registration Ltd
|
|
31745.01.01
|
TECENTRIQ C/S.SOL.IN 1200MG/VIAL (20ML) 1 VIAL x 20ML
|
|
4.085,52 € |
4.543,94 € |
4.912,91 € |
Roche Registration Ltd
|
|
23551.03.01
|
VIRACEPT F.C.TAB 250MG/TAB FLX270
|
|
223,74 € |
257,17 € |
305,84 € |
Roche Registration Ltd
|
|
23551.01.01
|
VIRACEPT ORAL.PD 50MG/G FLX144G
|
|
30,22 € |
34,74 € |
48,99 € |
Roche Registration Ltd
|
|
24712.01.01
|
XELODA F.C.TAB 150MG/TAB BTx60(BLIST6x10)
|
|
18,96 € |
21,80 € |
30,04 € |
Roche Registration Ltd
|
|
24712.02.01
|
XELODA F.C.TAB 500MG/TAB BTx120(BLIST12x10)
|
|
112,01 € |
128,76 € |
158,32 € |
Roche Registration Ltd
|
|
23457.01.02
|
XENICAL CAPS 120MG/CAP BTX42(BLISTERS)
|
|
13,19 € |
15,16 € |
21,38 € |
Roche Registration Ltd
|
|
30215.01.01
|
ZELBORAF F.C.TAB 240MG/TAB BTx56 (BLISTER ALU/ ALU) ALU)
|
|
1.122,71 € |
1.248,68 € |
1.389,78 € |
Roche Registration Ltd
|
|
23852.02.01
|
ZENAPAX 1 BOX * 3 VIAL * 5 ML
|
|
|
|
|
Roche Registration Ltd
|
